Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Glen R. Bressner acquired 8,500 shares of the company’s stock in a transaction on Tuesday, October 4th. The stock was purchased at an average cost of $12.00 per share, for a total transaction of $102,000.00. Following the completion of the transaction, the director now owns 2,793,932 shares in the company, valued at approximately $33,527,184. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) opened at 13.08 on Friday. The firm has a 50 day moving average of $14.19 and a 200-day moving average of $14.19. Tabula Rasa HealthCare Inc has a 12 month low of $12.63 and a 12 month high of $16.17.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.